← Back
$NBIX All transactions

NEUROCRINE BIOSCIENCES INC

M 10b5-1 Plan

$ Value

$0

Shares

1,812

Price

$0

Filed

Jan 20

Insider

Name

Gano Kyle

Title

Chief Executive Officer

CIK

0001567160

Roles

Director Officer

Transaction Details

Transaction Date

2026-01-16

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2025. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. | Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $131.42 to $133.98. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range | Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $131.49 to $133.79. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range | The option was granted February 5, 2016 and vested in 48 equal monthly installments beginning on March 5, 2016. These options were due to expire on February 5, 2026.

Filing Info

Accession No.

0001567160-26-000002

Form Type

4

Issuer CIK

0000914475

Gano Kyle's History

Date Ticker Type Value
2026-02-13 NBIX M $0
2026-02-13 NBIX F $150K
2026-02-13 NBIX M $0
2026-02-13 NBIX F $172K
2026-02-13 NBIX A $0
2026-02-13 NBIX F $668K
2026-02-13 NBIX M $0
2026-02-13 NBIX M $0
2026-02-13 NBIX A $0
2026-02-13 NBIX A $0

Other Insiders at NBIX (90d)

Insider Bought Sold Last
GORMAN KEVIN CHARLES 2026-02-13
Lippoldt Darin
Chief Legal Officer
2026-02-13
Gano Kyle
Chief Executive Officer
2026-02-13
BENEVICH ERIC
Chief Commercial Officer
2026-02-13
ABERNETHY MATT
Chief Financial Officer
2026-03-04
Cooke Julie
Chief Human Resources Officer
2026-02-13
Keswani Sanjay Chandru
Chief Medical Officer
2026-02-13
Onyia Jude
Chief Scientific Officer
2026-02-20
Boyer David W.
Chief Corp. Affairs Officer
2026-02-13
Delaet Ingrid
Chief Regulatory Officer
2026-02-13